ArticleFrontiers in pharmacology2021

LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling.

Emilio R Mustafá et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.